Kaia Health, which makes apps that help manage chronic pain using AI and motion-tracking tech, raises $75M Series C, bringing its total raised to $125M
Kaia Health is on a mission to make access to virtual physical therapy for conditions such as musculoskeletal (bones and cartilage) …
Context & Ripple Effects
This round caps a fast escalation for Kaia Health: a $10M Series A in early 2019, then a $26M Series B just over a year later, and now a $75M Series C that triples its cumulative funding to $125M. The company sits in a crowded digital chronic-pain field alongside AppliedVR, which raised a $36M Series B later that same year, and AI primary-care player K Health.
The payoff line arrives years later: New York-based Sword Health, itself an AI-powered remote physical-therapy developer, agrees to acquire Kaia Health for $285M — roughly double the total capital Kaia had raised when this Series C closed.
First-order effects
- Kaia Health gains the largest war chest in its history — more than half of its $125M total raised comes from this single round — to scale virtual physical therapy for musculoskeletal conditions against funded rivals like AppliedVR.
Second-order effects
- Competitors must match the funding pace or differentiate: AppliedVR's $36M raise shows the chronic-pain therapeutics category attracting comparable Series B-scale checks, pushing rivals toward larger rounds or niche positioning.
Third-order effects
- The pattern ends in consolidation rather than independent scale: Sword Health's eventual $285M acquisition of Kaia Health suggests well-funded digital pain startups become acquisition targets for category leaders once their capital needs outgrow what incremental rounds can support.
The trend: AI-driven digital therapeutics are moving through a fund-then-consolidate cycle, where successive venture rounds build valuation until a scaled acquirer absorbs the startup.